Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases

Clinical Rheumatology

Volumn 26, Issue 11, 2007, Pages 1913-1915

  Tufan, Fatih ^a   Kamali, Sevil ^a   Erer, Burak ^a   Gul, Ahmet ^a   Inanc, Murat ^a   Ocal, Lale ^a   Konice, Meral ^a   Aral, Orhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adverse events; Intravenous immunoglobulin; Safety

Indexed keywords

IMMUNOGLOBULIN G;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FREQUENCY ANALYSIS; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; INFECTION; MALE; NEUTROPENIA; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTOPENIA; THROMBOEMBOLISM; VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; CHILD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 34948838954     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0694-y     Document Type: Article

References (14)

1. Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L et al (2005) Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatol Int 25:211-214
2. Imbach P, Wagner H, Berchtold W, Gaedicke G, Hirt A, Joller P et al (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2:464-468
3. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treament of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
4. Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747-755
5. Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484-486
6. Orbach H, Katz U, Sherer Y, Schoenfeld Y (2005) Intravenous immunoglobulin: Adverse effects and safe administration. Clin Rev Allergy Immunol 29:173
7. Schiavotto C, Ruggeri M, Rodeghiero F (1993) Adverse reactions after high-dose intravenous immunoglobulin: Incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 78(6 Suppl 2):35-40
8. Tan EM (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
9. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107
10. Dalakas MC (1988) A classification of polymyositis and dermatomyositis. In: Dalakas MC (ed) Polymyositis and dermatomyositis. Butterworth, Boston, pp 1-16
11. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42:1309-1311
12. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB et al (2001) A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44(4):912-920
13. Katz U, Shoenfeld Y (2005) Review: Intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14(10):802-808
14. Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC et al (2005) Brief communication: High incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 142(8):620-626